Incidence of CMV disease One year post enrollment [clinicaltrials_resource:969dacb5faa9924f0b001410a2dcd232]
CMV disease occurring after completion of prophylaxis or monitored CMV viremia testing
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Incidence of CMV disease One year post enrollment [clinicaltrials_resource:969dacb5faa9924f0b001410a2dcd232]
CMV disease occurring after completion of prophylaxis or monitored CMV viremia testing
Bio2RDF identifier
969dacb5faa9924f0b001410a2dcd232
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:969dacb5faa9924f0b001410a2dcd232
measure [clinicaltrials_vocabulary:measure]
Incidence of CMV disease
time frame [clinicaltrials_vocabulary:time-frame]
One year post enrollment
description
CMV disease occurring after completion of prophylaxis or monitored CMV viremia testing
identifier
clinicaltrials_resource:969dacb5faa9924f0b001410a2dcd232
title
Incidence of CMV disease One year post enrollment
@en
type
label
Incidence of CMV disease One y ...... dacb5faa9924f0b001410a2dcd232]
@en